Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 6, 2020; 8(23): 6158-6163
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.6158
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.6158
Uncontrolled central hyperthermia by standard dose of bromocriptine: A case report
Xin Ge, Department of Intensive Care Unit, Wuxi 9th Affiliated Hospital of Soochow University, Hand Institution of Wuxi City, Wuxi 214000, Jiangsu Province, China
Xin Ge, Traumatic Center, Wuxi 9th Affiliated Hospital of Soochow University, Hand Institution of Wuxi City, Wuxi 214000, Jiangsu Province, China
Xue Luan, Department of Neurosurgery, Central Hospital of Jinzhou, Jinzhou 121000, Liaoning Province, China
Author contributions: Ge X contributed to the concept, drafting, reporting, and revising of the case; Luan X acquired clinical data and revised the manuscript. All authors have read and approved the final manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xin Ge, MD, PhD, Assistant Professor, Director, Department of intensive care unit, Wuxi 9th Affiliated Hospital of Soochow University, Hand Institution of Wuxi City, No. 999 Liangxi Road, WuXi 214000, Jiangsu Province, China. sirgexin@163.com
Received: July 11, 2020
Peer-review started: July 11, 2020
First decision: September 24, 2020
Revised: September 30, 2020
Accepted: October 20, 2020
Article in press: October 20, 2020
Published online: December 6, 2020
Processing time: 146 Days and 2.6 Hours
Peer-review started: July 11, 2020
First decision: September 24, 2020
Revised: September 30, 2020
Accepted: October 20, 2020
Article in press: October 20, 2020
Published online: December 6, 2020
Processing time: 146 Days and 2.6 Hours
Core Tip
Core Tip: Central hyperthermia is characterized by a high core temperature and a poor response to antipyretics and antibiotics. No guidelines on how to treat central hyperthermia have been developed for clinical practice, but bromocriptine has been reported to control the condition effectively. A unique female patient who had central hyperthermia that could not be controlled by a standard dose of bromocriptine was treated in our department. We prescribed 30 mg bromocriptine per day to control her hyperpyrexia.